Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification

Ähnliche Einträge

• Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
  von: Gökhan Şahin, et al.
  Veröffentlicht: (2025)
• Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
  von: Georges Gebrael, et al.
  Veröffentlicht: (2024)
• Promising long‐term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer
  von: Mary Beth Nierengarten
  Veröffentlicht: (2024)
• A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma
  von: Yousef Zakharia, et al.
  Veröffentlicht: (2026)
• Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
  von: Feng‐Pai Tsai, et al.
  Veröffentlicht: (2024)